FDA disallows Avastin as breast-cancer drug
Avastin is no longer approved for treating metastatic breast cancer because it exposes patients to dangerous side effects without any benefit, the U.S. Food and Drug Administration said Friday.
The FDA noted that Avastin’s risks include severely high blood pressure, bleeding, heart attacks, and perforations in such body parts as the nose, stomach, and intestines.
Read more: http://www.philly.com/philly/business/134159658.html#ixzz1eCV7CTP6
FDA revokes approval of Avastin for breast cancer
The government delivered a blow to some desperate patients Friday as it ruled the blockbuster drug Avastin should no longer be used to treat advanced breast cancer.
Avastin is hailed for treating colon cancer and certain other malignancies. But the Food and Drug Administration said it appeared to be a false hope for breast cancer: Studies haven’t found that it helps those patients live longer or brings enough other benefit to outweigh its dangerous side effects.
If you or a loved one has suffered any of the above serious Avastin side effects, or other serious side effects from Avastin, please contact your doctor immediately. You are also urged to contact the law firm of Audet & Partners, LLP to protect your legal rights. You may call us toll-free at 800.965.1461, or you may use this secure form.